Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.99B |
| 2 |
Apple
AAPL
|
+$2.23B |
| 3 |
NVIDIA
NVDA
|
+$1.92B |
| 4 |
Amazon
AMZN
|
+$1.75B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altair Engineering Inc
ALTR
|
+$152M |
| 2 |
Merck
MRK
|
+$142M |
| 3 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$141M |
| 4 |
ALTM
Arcadium Lithium plc
ALTM
|
+$132M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.36% |
| 2 | Financials | 14.54% |
| 3 | Healthcare | 11.04% |
| 4 | Consumer Discretionary | 10.44% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MAZE
2976
Maze Therapeutics
MAZE
$1.59B
| $2.34M | ﹤0.01% |
+212,464
| New | +$2.56M |
|
|
FBLA
2977
FB Bancorp
FBLA
$251M
| $2.34M | ﹤0.01% |
207,462
+3,169
| +2% | +$36.3K |
|
2978
GDS Holdings
GDS
$6.41B
| $2.34M | ﹤0.01% |
92,188
-4,745
| -5% | -$144K |
|
2979
Xenon Pharmaceuticals
XENE
$6.12B
| $2.33M | ﹤0.01% |
69,597
+68
| +0.1% | +$2.58K |
|
2980
Sera Prognostics
SERA
$81.1M
| $2.33M | ﹤0.01% |
634,252
+34,550
| +6% | +$176K |
|
2981
Contango Silver & Gold Inc
CTGO
$652M
| $2.33M | ﹤0.01% |
228,252
+6,178
| +3% | +$63.1K |
|
2982
C&F Financial
CFFI
$286M
| $2.33M | ﹤0.01% |
34,523
+1,252
| +4% | +$93.7K |
|
2983
Townsquare Media
TSQ
$118M
| $2.31M | ﹤0.01% |
283,472
+2,575
| +0.9% | +$22.4K |
|
2984
MoonLake Immunotherapeutics
MLTX
$1.55B
| $2.3M | ﹤0.01% |
58,994
+44
| +0.1% | +$1.9K |
|
2985
Abeona Therapeutics
ABEO
$413M
| $2.3M | ﹤0.01% |
482,619
+18,892
| +4% | +$103K |
|
2986
Virco
VIRC
$96.3M
| $2.3M | ﹤0.01% |
242,831
+2,960
| +1% | +$30.8K |
|
2987
Camtek
CAMT
$7.25B
| $2.29M | ﹤0.01% |
39,141
+24
| +0.1% | +$1.93K |
|
2988
C4 Therapeutics
CCCC
$412M
| $2.29M | ﹤0.01% |
1,430,288
+49,202
| +4% | +$147K |
|
|
RGLS
2989
DELISTED
Regulus Therapeutics
RGLS
| $2.28M | ﹤0.01% |
1,300,818
+21,487
| +2% | +$28.4K |
|
|
EVBN
2990
DELISTED
Evans Bancorp Inc
EVBN
| $2.27M | ﹤0.01% |
58,201
+2,285
| +4% | +$95.9K |
|
2991
Blink Charging
BLNK
$87.9M
| $2.26M | ﹤0.01% |
2,467,020
+177,913
| +8% | +$206K |
|
2992
Taylor Devices
TAYD
$175M
| $2.26M | ﹤0.01% |
70,139
+2,714
| +4% | +$89.1K |
|
2993
Eledon Pharmaceuticals
ELDN
$285M
| $2.26M | ﹤0.01% |
666,717
+3,616
| +0.5% | +$14.9K |
|
2994
Hagerty
HGTY
$1.39B
| $2.26M | ﹤0.01% |
249,557
+8,630
| +4% | +$83.7K |
|
2995
Editas Medicine
EDIT
$442M
| $2.26M | ﹤0.01% |
1,943,777
+135,214
| +7% | +$199K |
|
|
IAUX
2996
i-80 Gold Corp
IAUX
$1.4B
| $2.25M | ﹤0.01% |
3,862,751
-24,096
| -0.6% | -$15.6K |
|
2997
Everspin Technologies
MRAM
$405M
| $2.25M | ﹤0.01% |
440,332
+11,852
| +3% | +$68.7K |
|
|
MRX
2998
Marex Group Limited Ordinary Shares
MRX
$4.37B
| $2.25M | ﹤0.01% |
63,591
-4,317
| -6% | -$150K |
|
|
PWOD
2999
DELISTED
Penns Woods Bancorp
PWOD
| $2.23M | ﹤0.01% |
80,050
+2,187
| +3% | +$65.2K |
|
3000
Kodiak Sciences
KOD
$2.84B
| $2.23M | ﹤0.01% |
793,593
+24,899
| +3% | +$135K |
|
Similar funds
Geode Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Geode Capital Management held 4,591 positions worth $1.27T, down 1.4% from $1.29T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Geode Capital Management deployed $47.9B of net new capital in Q1 2025, opening 122 new positions and adding to 3,780 existing holdings. Its largest new stake was Sandisk: 1,936,245 shares worth $92.2M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Merck, an estimated $142M trimmed.
- Geode Capital Management's largest Q1 2025 buy was Sandisk: 1,936,245 shares worth $92.2M.
- Geode Capital Management added most to Microsoft in Q1 2025, an estimated $2.99B increase.
- Geode Capital Management's biggest Q1 2025 reduction was Merck, cutting an estimated $142M.
- Geode Capital Management fully exited Altair Engineering Inc in Q1 2025, selling an estimated $152M.
- Geode Capital Management's ten largest holdings make up 29% of its $1.27T portfolio in Q1 2025.
- Geode Capital Management opened 122 new positions and closed 115 in Q1 2025.
- Geode Capital Management's portfolio value fell 1.4% quarter-over-quarter to $1.27T.
Based on Geode Capital Management's 13F filing for Q1 2025, filed 13 May 2025.